The blinded blood pressure monitor and scale allows blind data monitoring, where participants can take readings but not see ...

Investigators compared outcomes between patients with stage II/III colon cancer given adjuvant aspirin and those given ...

An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...

BiomX Inc. PHGE recently announced the presentation of data from its Phase 1b/2a study for BX004 — a fixed multi-phage ...

Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial (1) and cervical cancers (2) who gain clinically meaningful benefit from adding immunotherapy to current standard ...

Patients with locally advanced cervical cancer were randomized to receive either pembrolizumab or placebo in combination with ...

The Alliance for Clinical Trials in Oncology today announced that final results will be presented at ESMO 2024 from CABINET ...

At the European Association for the Study of Diabetes annual meeting, Novo Nordisk A/S (NYSE:NVO) shared an abstract with ...

Three months of supplementation with a prebiotic blend of inulin and oligofructose may significantly improve measures of ...

Dr. Luba Yammine is investigating a treatment that could help smokers both quit and sidestep the weight gain that could stand ...

Pembrolizumab combined with chemoradiotherapy followed by pembrolizumab monotherapy significantly improved survival compared ...

Statistically significant mean weight loss up to 5.5% over 28 days (4.9% placebo adjusted)Well-tolerated with no treatment-related dose ...